Comparison of Methicillin-Resistant Staphylococcus aureus Community-Acquired and Healthcare-Associated Pneumonia
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as an important cause of not only healthcare-associated pneumonia (HCAP) but also community-acquired pneumonia (CAP). We determined the impact of MRSA on differences in clinical characteristics, courses, and outcomes between CAP and HCAP. Materials and Methods: We conducted a retrospective observational study on 78 adult patients admitted with MRSA pneumonia at a university-affiliated tertiaryhospital between January 2008 and December 2011. We compared baseline characteristics, chest radiographs, treatment outcomes, and drug resistance patterns between the CAP and HCAP groups. Results: Of the 78 patients with MRSA pneumonia,57 (73.1%) were HCAP and 21 (26.9%) were CAP. MRSA infection history in the previous year (29.8% vs. 14.3%, p=0.244) tended to be more common in HCAP than in CAP. Despite similar Pneumonia Severity Index scores (151 in CAP vs. 142 in HCAP), intubation rates (38.1% vs. 17.5%; p=0.072) and intensive care unit admission (42.9% vs. 22.8%; p=0.095) tended to be higher in the CAP group, while 28-day mortality was higher in the HCAP group (14.3% vs. 26.3%; p=0.368), although without statistical significance. All patients showed sensitivity to vancomycinand linezolid; meanwhile, HCAP patients showed greater resistance to gentamicinthan CAP patients (58.3% vs. 16.6%; p=0.037). The median total hospital charges were 6899 American dollars for CAP and 5715 American dollars for HCAP (p=0.161). Conclusion: MRSA pneumonia showed significantly differences in baseline characteristics, chest radiographs, treatment outcomes, and medical expensesbetween HCAP and CAP groups.
Abstract
Purpose: Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as an important cause of not only healthcare-associated pneumonia (HCAP) but also community-acquired pneumonia (CAP). We determined the impact of MRSA on differences in clinical characteristics, courses, and outcomes between CAP and HCAP. Materials and Methods: We conducted a retrospective observational study on 78 adult patients admitted with MRSA pneumonia at a university-affiliated tertiaryhospital between January 2008 and December 2011. We compared baseline characteristics, chest radiographs, treatment outcomes, and drug resistance patterns between the CAP and HCAP groups. Results: Of the 78 patients with MRSA pneumonia,57 (73.1%) were HCAP and 21 (26.9%) were CAP. MRSA infection history in the previous year (29.8% vs. 14.3%, p=0.244) tended to be more common in HCAP than in CAP. Despite similar Pneumonia Severity Index scores (151 in CAP vs. 142 in HCAP), intubation rates (38.1% vs. 17.5%; p=0.072) and intensive care unit admission (42.9% vs. 22.8%; p=0.095) tended to be higher in the CAP group, while 28-day mortality was higher in the HCAP group (14.3% vs. 26.3%; p=0.368), although without statistical significance. All patients showed sensitivity to vancomycinand linezolid; meanwhile, HCAP patients showed greater resistance to gentamicinthan CAP patients (58.3% vs. 16.6%; p=0.037). The median total hospital charges were 6899 American dollars for CAP and 5715 American dollars for HCAP (p=0.161). Conclusion: MRSA pneumonia showed significantly differences in baseline characteristics, chest radiographs, treatment outcomes, and medical expensesbetween HCAP and CAP groups.
참고문헌 (29)
- Rubinstein E, "Pneumonia caused by methicillin-resistant Staphylococcus aureus", Clin Infect Dis, 46(Suppl 5), pp.S378~S385 (2008)
- Sievert DM, "Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010", Infect Control Hosp Epidemiol, 34, pp.1~14 (2013)
- Park HK, "Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital", Respir Med, 104, pp.1729~1735 (2010)
- Schreiber MP, "Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?", Chest, 137, pp.1283~1288 (2010)
- Shindo Y, "Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital", Chest, 135, pp.633~640 (2009)
- Moran GJ, "Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia", Clin Infect Dis, 54, pp.1126~1133 (2012)
- Rello J, "Microbiological testing and outcome of patients with severe community-acquired pneumonia", Chest, 123, pp.174~180 (2003)
- Lobo LJ, "Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia", Chest, 138, pp.130~136 (2010)
- Kallen AJ, "Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season", Ann Emerg Med, 53, pp.358~365 (2009)
- Gillet Y, "Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin", Clin Infect Dis, 45, pp.315~321 (2007)
- Hidron AI, "Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia", Lancet Infect Dis, 9, pp.384~392 (2009)
- Liu C, "Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children", Clin Infect Dis, 52, pp.e18~e55 (2011)
- Nathwani D, "Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community", J Antimicrob Chemother, 61, pp.976~994 (2008)
- Mylotte JM, "Nursing home-acquired pneumonia", Clin Infect Dis, 35, pp.1205~1211 (2002)
- Muder RR, "Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention", Am J Med, 105, pp.319~330 (1998)
- Friedman ND, "Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections", Ann Intern Med, 137, pp.791~797 (2002)
- Carratalà J, "Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients", Ann Intern Med, 142, pp.165~172 (2005)
- American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
- Micek ST, "Health care-associated pneumonia and community-acquired pneumonia: a single-center experience", Antimicrob Agents Chemother, 51, pp.3568~3573 (2007)
- Murray PR, "Microscopic and baceriologic analysis of expectorated sputum", Mayo Clin Proc, 50, pp.339~344 (1975)
- 김명희, "Detection of Methicillin-Resistant Staphylococcus aureus in Healthcare Workers Using Real-Time Polymerase Chain Reaction", Yonsei Medical Journal, 54(5), pp.1282~1284 (2013), 연세대학교의과대학[DOI]
- Defres S, "MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia", Eur Respir J, 34, pp.1470~1476 (2009)
- Carratalà J, "Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes", Arch Intern Med, 167, pp.1393~1399 (2007)
- Kollef MH, "Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia", Chest, 128, pp.3854~3862 (2005)
- Gillet Y, "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients", Lancet, 359, pp.753~759 (2002)
- Hageman JC, "Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season", Emerg Infect Dis, 12, pp.894~899 (2006)
- Gonzalez BE, "Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection", Clin Infect Dis, 41, pp.583~590 (2005)
- Shorr AF, "Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia", J Clin Microbiol, 48, pp.3258~3262 (2010)
- Shallcross LJ, "The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis", Lancet Infect Dis, 13, pp.43~54 (2013)